Thursday, December 19, 2013

European boycott of death penalty drugs lowers rate of US executions

New Death Penalty Information Center report claims there were 39 executions this year – the lowest number since 1994.

The European-led boycott of medical drugs used by US corrections departments to execute prisoners is having such an impact that it has driven the number of executions to an almost all-time low, a leading authority on the death penalty has concluded.

The year-end report for 2013 from the Death Penalty Information Center, based in Washington, records that there were 39 executions this year – only the second time since 1994 that the number has fallen below 40. The report says a major factor behind the slump in judicial killings has been the difficulty states that still practice the death penalty are encountering in finding a consistent means of ending life.

California, Arkansas and North Carolina have all had effective moratoriums for the past seven years because they have failed to settle on a workable lethal injection protocol. Several other states are turning to untested drugs or to lethal medicines improvised in single batches by so-called “compounding pharmacies” that are not subject to federal regulations.

“The goal-posts keep shifting under the death penalty states,” said Richard Dieter, director of the Death Penalty Information Center and lead author of the report. “As soon as they move to a new protocol, the boycott spreads.”

The European Commission imposed tough restrictions on the export of anaesthetics to US corrections departments in 2011, and amid the squeeze a succession of states has been running out of their primary lethal drugs supplies. As a result, Florida has turned to midazolam hydrochloride, a drug never before used in executions, provoking an outcry that it might be inflicting cruel and unusual punishment on condemned prisoners.


Source: The Guardian, December 18, 2013

No comments:

Post a Comment